Guided Therapeutics Inc (GTHP) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
5835 PEACHTREE CORNERS EAST PEACHTREE CORNERS, GA 30092 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 643 | 182 | 899 | 1 | 14 | |||
| Cash and cash equivalents | 643 | 182 | 899 | 1 | 14 | |||
| Receivables | 172 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 571 | 605 | 48 | 114 | 265 | 773 | ||
| Inventory | 571 | 605 | 48 | 114 | 265 | 773 | ||
| Other current assets | 377 | 85 | 70 | 69 | 111 | 259 | ||
| Other undisclosed current assets | (126) | 24 | 13 | 13 | 3 | |||
| Total current assets: | 1,637 | 896 | 1,030 | 196 | 380 | 1,046 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 372 | 453 | 132 | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 14 | 1 | 21 | 49 | 126 | |||
| Other noncurrent assets | 17 | |||||||
| Other undisclosed noncurrent assets | 18 | 19 | 60 | 320 | ||||
| Total noncurrent assets: | 403 | 454 | 150 | 40 | 109 | 446 | ||
| TOTAL ASSETS: | 2,040 | 1,350 | 1,180 | 236 | 489 | 1,492 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 4,740 | 7,133 | 7,375 | 7,319 | 9,679 | 7,222 | ||
| Accounts payable | 2,362 | 2,419 | 2,897 | 3,013 | 3,019 | 2,600 | ||
| Accrued liabilities | 1,768 | 2,995 | 3,235 | 3,156 | 4,247 | 2,670 | ||
| Employee-related liabilities | 1,123 | 1,030 | 2,122 | 1,656 | ||||
| Interest and dividends payable | 610 | 1,719 | 120 | 120 | 291 | 296 | ||
| Deferred revenue | 337 | 42 | ✕ | ✕ | ✕ | |||
| Debt | 136 | 73 | 1,335 | 1,080 | 1,874 | 1,476 | ||
| Due to related parties | 87 | 116 | 136 | |||||
| Other undisclosed current liabilities | 394 | 1,598 | 3,564 | 2,593 | 376 | 640 | ||
| Total current liabilities: | 5,694 | 8,962 | 12,410 | 10,992 | 11,929 | 9,338 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 325 | 415 | 44 | 340 | ||||
| Long-term debt, excluding current maturities | 23 | 15 | 340 | |||||
| Operating lease, liability | 325 | 392 | 29 | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 624 | 625 | 569 | 340 | ||||
| Due to related parties | 592 | 600 | 569 | 340 | ||||
| Derivative instruments and hedges, liabilities | 32 | 25 | ||||||
| Other undisclosed noncurrent liabilities | 842 | 2,203 | 5,092 | 4,388 | 7,962 | 1,420 | ||
| Total noncurrent liabilities: | 1,791 | 3,243 | 5,705 | 5,068 | 7,962 | 1,420 | ||
| Total liabilities: | 7,485 | 12,205 | 18,115 | 16,060 | 19,891 | 10,758 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (5,445) | (10,855) | (16,935) | (15,824) | (19,402) | (9,266) | ||
| Common stock | 3,403 | 3,403 | 3,394 | 2,877 | 791 | 742 | ||
| Treasury stock, value | (132) | (132) | (132) | (132) | (132) | (132) | ||
| Common stock, value, subscriptions | 351 | 692 | 276 | |||||
| Additional paid in capital | 126,800 | 123,109 | 118,552 | 118,259 | 117,416 | 116,380 | ||
| Accumulated deficit | (142,387) | (139,956) | (139,555) | (137,634) | (138,533) | (127,558) | ||
| Other undisclosed stockholders' equity attributable to parent | 6,520 | 2,721 | 806 | 114 | 780 | 1,302 | ||
| Total stockholders' equity: | (5,445) | (10,855) | (16,935) | (15,824) | (19,402) | (9,266) | ||
| TOTAL LIABILITIES AND EQUITY: | 2,040 | 1,350 | 1,180 | 236 | 489 | 1,492 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 81 | 102 | 36 | 57 | 18 | 68 | |
| Other income | 507 | 271 | 48 | 54 | 18 | 68 | |
| Cost of revenue | (70) | (89) | (530) | (493) | |||
| Cost of goods and services sold | (530) | (493) | |||||
| Other undisclosed gross profit | (61) | 41 | 226 | 537 | |||
| Gross profit: | 20 | 143 | (34) | (32) | (286) | 112 | |
| Operating expenses | (2,382) | (1,195) | (903) | (1,516) | (2,835) | (3,932) | |
| Operating loss: | (2,362) | (1,052) | (937) | (1,548) | (3,121) | (3,820) | |
| Nonoperating income (expense) | 292 | 773 | (984) | 3,209 | (7,575) | (150) | |
| Debt instrument, convertible, beneficial conversion feature | 645 | ||||||
| Other nonoperating income (expense) | 292 | 773 | (984) | 2,564 | (7,575) | (150) | |
| Interest and debt expense | 578 | (296) | (1,412) | 1,039 | (1,106) | (1,895) | |
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (578) | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (2,070) | (575) | (3,333) | 2,700 | (11,802) | (5,865) | |
| Other undisclosed income (loss) from continuing operations before income taxes | 296 | 1,412 | (1,684) | 1,106 | 1,895 | ||
| Net income (loss) attributable to parent: | (2,070) | (279) | (1,921) | 1,016 | (10,696) | (3,970) | |
| Preferred stock dividends and other adjustments | (122) | (116) | (278) | (1,025) | |||
| Other undisclosed net loss available to common stockholders, basic | (361) | ||||||
| Net income (loss) available to common stockholders, diluted: | (2,431) | (401) | (1,921) | 900 | (10,974) | (4,995) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,070) | (279) | (1,921) | 1,016 | (10,696) | (3,970) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (2,070) | (279) | (1,921) | 1,016 | (10,696) | (3,970) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.